However, there is much more aPL, among them anti-phosphatidylserine/prothrombin (aPS/PT) complex antibodies, aβ2GPI antibodies against domain I (aβ2GPIDI) and anti IgA class (aβ2GPI IgA) were also described as highly associated with APS symptoms [2–4]. The gene discussed is CD79A; the disease is autoimmune polyendocrinopathy.